Divi's Laboratories Q3 Results: Net profit rises 64.5% YoY to ₹589 crore, stock surges nearly 4%

  • Divi's Laboratories Q3 Results: Divi's Laboratories reported a 64.5% YoY rise in Q3FY25 net profit to 589 crore, with revenue up 25.01% to 2,319 crore. The share price rose nearly 4% to 5,835.65. The Kakinada Project is partially operational and expected to be fully functional in 6 months.

Dhanya Nagasundaram
Published3 Feb 2025, 01:07 PM IST
Divi's Laboratories Q3 Results:
AFP PHOTO / JEAN-CHRISTOPHE VERHAEGEN
Divi's Laboratories Q3 Results: AFP PHOTO / JEAN-CHRISTOPHE VERHAEGEN

Divi's Laboratories Q3 Results: Divi's Laboratories on Monday reported an 64.5% year-on-year rise in its consolidated net profit (attributable to Shareholders of the Company) for the fiscal's third quarter ended December (Q3FY25) to 589 crore. The company had reported a profit of 358 crore in the year-ago period. Sequentially, the consolidated net profit was up 15.5%. Divi's Lab share price today at 13:22 was trading nearly 4% higher at 5835.65 apiece on BSE.

Divi's Lab's consolidated revenue from operations at 2,319 crores during the quarter ended December (Q3FY25) from 1,855 crore in Q3FY24, a year-on-year rise of 25.01%. Sequentially, the revenue was down by nearly 1%.

Profit before tax (PBT) for the quarter amounted to 726 crore as against a PBT of 489 crore for the corresponding quarter of the previous year.

Also Read | UPL share price hits 52-week high extending post-Q3 results rally for 3rd day

“For the current quarter, we have forex gain of 10 crores as against a gain of 18 crores during the corresponding quarter of the previous year,” the company said in an exchange filing.

The company recently provided an update regarding its capital expenditure program, noting that a portion of the Kakinada Project (Unit-III) has begun commercial operations as of January 1, 2025. The remainder of the Kakinada project is currently in the implementation phase and is anticipated to be operational within approximately six months.

“We have capitalised assets of 433 for the quarter and of 557 crores for the 9-month period of the current year. Of this, capitalisation for Kakinada Project is 418 crores during the 9-month period,” said the company.

Also Read | IOC, BPCL to HPCL: Why are OMC stocks nosediving? EXPLAINED

Divi's Lab share price today

According to Prashanth Tapse, Research Analyst, Senior Vice President of Research at Mehta Equities, post results the stock has given a strong breakout above its recent swing high resistance level of 5,600 and is holding well above this mark. A strict stop loss at 5,500 is recommended, as the stock is poised for an upside move towards 6,000 and beyond. A strong technical structure indicating a price reversal makes this a favourable buy.

Results were above street expectation as PAT jumps 64% YoY to 589 Cr, revenue up 25%.

 

Also Read | Paytm share price jumps 5% after arm acquires 25% in US-based company

Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decisions.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Business NewsMarketsDivi's Laboratories Q3 Results: Net profit rises 64.5% YoY to ₹589 crore, stock surges nearly 4%
MoreLess
First Published:3 Feb 2025, 01:07 PM IST